Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nuvation Bio Inc (NUVB)

Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nuvation Bio Inc 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 USA

www.nuvationbio.com Employees: 220 P: 332-208-6102

Sector:

Medical

Description:

Nuvation Bio Inc. is a biopharmaceutical company. It engages in developing differentiated and novel therapeutic candidates for unmet needs in oncology. Nuvation Bio Inc., formerly known as Panacea Acquisition Corp., is based in NEW YORK.

Key Statistics

Overview:

Market Capitalization, $K 3,222,630
Enterprise Value, $K 3,193,190
Shares Outstanding, K 342,833
Annual Sales, $ 7,870 K
Annual Net Income, $ -567,940 K
Last Quarter Sales, $ 13,120 K
Last Quarter Net Income, $ -55,790 K
EBIT, $ -232,960 K
EBITDA, $ -232,280 K
60-Month Beta 1.58
% of Insider Shareholders 29.93%
% of Institutional Shareholders 61.67%
Float, K 240,223
% Float 70.07%
Short Interest 52,606
Short Float 15.34%
Short Volume Ratio 0.63

Growth:

1-Year Return 233.33%
3-Year Return 389.58%
5-Year Return -19.66%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 11/03/25
Next Earnings Date 03/05/26
Earnings Per Share ttm -0.64
EPS Growth vs. Prev Qtr 5.88%
EPS Growth vs. Prev Year -6.67%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NUVB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -54.99%
Return-on-Assets % -38.12%
Profit Margin % -7,216.52%
Debt/Equity 0.16
Price/Sales 414.55
Price/Cash Flow N/A
Price/Book 9.83
Book Value/Share 0.95
Interest Coverage -1,669.41
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar